FDA Approves CBD Drug For Seizures Linked To Rare Disease
By Sarah Jarvis ( August 3, 2020, 4:13 PM EDT) -- The only U.S. Food and Drug Administration-approved drug containing a purified drug substance derived from cannabis has now been given the go-ahead by the agency to effectively treat seizures associated with a rare genetic disease....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.